DLX3
Homeobox protein DLX-3
Also known as: DLX3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60479
- Gene
- DLX3
- Ensembl
- ENSG00000064195
- Chromosome
- 17
- Canonical length
- 287 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Many vertebrate homeo box-containing genes have been identified on the basis of their sequence similarity with Drosophila developmental genes. Members of the Dlx gene family contain a homeobox that is related to that of Distal-less (Dll), a gene expressed in the head and limbs of the developing fruit fly. The Distal-less (Dlx) family of genes comprises at least 6 different members, DLX1-DLX6. Trichodentoosseous syndrome (TDO), an autosomal dominant condition, has been correlated with DLX3 gene mutation. This gene is located in a tail-to-tail configuration with another member of the gene family on the long arm of chromosome 17. Mutations in this gene have been associated with the autosomal dominant conditions trichodentoosseous syndrome and amelogenesis imperfecta with taurodontism. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
287 residues, UniProt reviewed canonical sequence.
>O60479|DLX3
1 MSGSFDRKLS SILTDISSSL SCHAGSKDSP TLPESSVTDL GYYSAPQHDY YSGQPYGQTV
61 NPYTYHHQFN LNGLAGTGAY SPKSEYTYGA SYRQYGAYRE QPLPAQDPVS VKEEPEAEVR
121 MVNGKPKKVR KPRTIYSSYQ LAALQRRFQK AQYLALPERA ELAAQLGLTQ TQVKIWFQNR
181 RSKFKKLYKN GEVPLEHSPN NSDSMACNSP PSPALWDTSS HSTPAPARSQ LPPPLPYSAS
241 PSYLDDPTNS WYHAQNLSGP HLQQQPPQPA TLHHASPGPP PNPGAVYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DLX3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- skin: 52 nTPM
- placenta: 7 nTPM
- blood vessel: 4 nTPM
- vagina: 3.7 nTPM
- esophagus: 2.9 nTPM
- tonsil: 2.8 nTPM
Single-cell type
- syncytiotrophoblasts: 111 nCPM
- extravillous trophoblasts: 97 nCPM
- migrating cytotrophoblasts: 54 nCPM
- cytotrophoblasts: 45 nCPM
- basal keratinocytes: 19 nCPM
- suprabasal keratinocytes: 14 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 2 nTPM
- cerebral cortex: 1 nTPM
- medulla oblongata: 0.9 nTPM
- pons: 0.8 nTPM
- spinal cord: 0.6 nTPM
- cerebellum: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DLX3.
Disease | AllUniProt
Conditions DLX3 is implicated in, by any mechanism.
- Trichodentoosseous syndrome (TDO) MIM:190320
- Amelogenesis imperfecta 4 (AI4) MIM:104510
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 215 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Tricho-dento-osseous syndrome
- Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism
- Inborn genetic diseases
- DLX3-related disorder
- Peripheral pulmonary artery stenosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.96
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel development
- BMP signaling pathway
- embryonic skeletal system development
- epithelial cell differentiation
- gene expression
- hair cell differentiation
- hair follicle morphogenesis
- odontoblast differentiation
- odontogenesis of dentin-containing tooth
- placenta development
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- Wnt signaling pathway
- hair follicle cell proliferation
Molecular functions
- chromatin binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DLX3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DLX3 as an antibody target. Whether an autoantibody or antibody against DLX3 could matter depends on whether native DLX3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DLX3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DLX3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...